Point of Care solutions
Bringing ultrafast molecular testing to the Point of Care
GNA is developing an ultrafast, portable, and low-cost sample-to-result platform for Point of Care (POC) molecular testing along with an infectious disease assay menu including tests for tuberculosis (TB), Methicillin-resistant Staphylococcus aureus (MRSA) and multi-drug resistant Gram-negative bacteria (MDRGN).
Democratizing molecular diagnostics at the Point of Care
Point of Care molecular testing remains complicated – and expensive. Our portable, low-cost, user-friendly platform will bring fast and sensitive molecular tests to the patients that need them, at the right place, at the right time.
For more information on point of care solutions please contact us at